Lindsey Wooliscroft is a Neurology physician affiliated with Oregon Health & Science University. OpenAlex indexes 30 publications with 244 citations (h-index 8); ClinicalTrials.gov lists 1 registered study matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
1015 NW 22nd Ave
Portland, OR 972103025
Telephone
503-413-8407Registry record last updated 2 Apr 2018.
Clinical trials
- Aerobic Exercise for Remyelination in Multiple Sclerosis
Sponsor: Oregon Health and Science University
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
2 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- TG Therapeutics, Inc.Program year20253 payments
- EMD Serono, Inc.Program year20221 payment
- EMD Serono, Inc.Program year20213 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Nervous system
40.5%Gabapentinoids23.7%Gabapentin62%Pregabalin38%Part D<11 patientsBenzodiazepine4.7%Diazepam100%Part D<11 patients+ 3 more classes in this area
Musculoskeletal
30.1%gamma-Aminobutyric Acid-ergic Agonist25.4%Baclofen100%Part D≥25 patientsCentral alpha-2 Adrenergic Agonist4.7%Tizanidine Hcl100%Part D<11 patientsCancer & immunology
25.8%CD20-directed Cytolytic Antibody9%Kesimpta Pen100%Part D<11 patientsInterferon beta8.4%Avonex (4 Pack)52%Rebif48%Part D<11 patients+ 1 more class in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
1 NIH research award on record, funded 2020–2024 per NIH RePORTER. The latest:
- Aerobic exercise to improve mobility in multiple sclerosis: optimizing design and execution for a full-scale multimodal remyelination clinical trial
Oregon Health & Science University
FY2024$159,729K23HD101667 - Aerobic exercise to improve mobility in multiple sclerosis: optimizing design and execution for a full-scale multimodal remyelination clinical trial
Oregon Health & Science University
FY2023$159,729K23HD101667 - Aerobic exercise to improve mobility in multiple sclerosis: optimizing design and execution for a full-scale multimodal remyelination clinical trial
Oregon Health & Science University
FY2022$159,729K23HD101667
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Effects of Mind-body Movement Interventions for Managing Symptoms in People with Multiple Sclerosis: An Overview of Reviews
Current Neurology and Neuroscience Reports
2026 - Perceptions of People With Multiple Sclerosis Who Practice Tai Chi and/or Qigong: A Mixed-Methods Study
International Journal of MS Care
2026 - Fall History is the Only Morse Fall Scale Item That Differentiates Nursing Home Residents Who Fall From Those Who do Not
Journal of the American Medical Directors Association
2026
Similar KOLs
Other experts from the same institution or the same specialty.
Eric Orwoll, MD
Oregon Health & Science University
Aaron Caughey, MD
Oregon Health & Science University
Tomasz Beer, MD
Oregon Health & Science University
John Nutt, MD
Oregon Health & Science University
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”